White House Opioid Commission: Access To Drug Therapy, Coverage 'Parity' Urged
Executive Summary
Industry's promotion and pricing behavior was a non-factor during the Christie-chaired meeting, which featured testimony from nine non-profit organizations working to resolve the opioid epidemic.
You may also be interested in...
White House Opioid Report Urges Better Access To Overdose Treatment; Mandatory Prescriber Education
Pricing of anti-addiction therapies could come under more pressure from HHS if Trump Administration accepts White House commission recommendation to declare public health emergency on opioid crisis.
Senate Adopts Cures Bill By Big Margin; FDA Could Tap $20m More In 2017
The Senate approved the same 21st Century Cures bill passed by the House last week on a 94-5 tally; the bill is expected to be quickly signed by President Obama. Provisions for extra dollars for FDA in the bill means that even with a plan by Congress to adopt a continuing resolution this week freezing FDA funding until April 28, the agency can rely on an additional $20 million set aside for it in Cures in the new year.
Accelerated Approvals Convert Much Faster If Confirmatory Trial Already Underway, FDA Cancer Data Shows
Oncology Center of Excellence’s ‘Project Confirm’ finds that if a confirmatory trial is ongoing at the time of accelerated approval, conversion to regular approval takes an average of three years versus 4.9 years if the trial starts after AA.